Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Evaluating the optimal time for amikacin administration with respect to haemodialysis using an in vitro pharmacodynamic simulation against epidemic nosocomial OXA-48 producing Klebsiella pneumoniae ST405 strains.

Carcas AJ, Sevillano D, González N, Alou L, Gómez-Gil R, Muñoz M, Llanos L, Sanchez-Villanueva RJ, Gonzalez-Parra E, Giménez MJ, Aguilar L.

J Glob Antimicrob Resist. 2019 Jun 6. pii: S2213-7165(19)30137-7. doi: 10.1016/j.jgar.2019.05.027. [Epub ahead of print]

PMID:
31176754
2.

Vegetable-Based Diets for Chronic Kidney Disease? It Is Time to Reconsider.

Cases A, Cigarrán-Guldrís S, Mas S, Gonzalez-Parra E.

Nutrients. 2019 Jun 4;11(6). pii: E1263. doi: 10.3390/nu11061263. Review.

3.

Criteria for classification of protein-energy wasting in dialysis patients: impact on prevalence.

Gracia-Iguacel C, González-Parra E, Mahillo I, Ortiz A.

Br J Nutr. 2019 May 14:1-8. doi: 10.1017/S0007114519000400. [Epub ahead of print]

PMID:
31084673
4.

Questioning the Safety of Calcidiol in Hemodialysis Patients.

Villa-Bellosta R, Mahillo-Fernández I, Ortíz A, González-Parra E.

Nutrients. 2019 Apr 26;11(5). pii: E959. doi: 10.3390/nu11050959.

5.

Higher Proportion of Non-1-84 PTH Fragments in Peritoneal Dialysis Patients Compared to Hemodialysis Patients Using Solutions Containing 1.75 mmol/l Calcium.

Sánchez-González C, Gonzalez-Casaus ML, Sellares VL, Albalate M, Torregrosa JV, Mas S, Ortiz A, Rodriguez M, Gonzalez-Parra E.

Front Physiol. 2018 Nov 20;9:1643. doi: 10.3389/fphys.2018.01643. eCollection 2018.

6.

Pharmacological interactions of phosphate binders.

Bover Sanjuán J, Navarro-González JF, Arenas MD, Torregrosa JV, Tamargo Menéndez J, de Francisco ALM, González-Parra E, Lloret Cora MJ, Sánchez Álvarez JE, Martín-Malo A, Molina Vila P, Bajo MA, DaSilva Santos I.

Nefrologia. 2018 Nov - Dec;38(6):573-578. doi: 10.1016/j.nefro.2018.05.003. Epub 2018 Jul 7. English, Spanish. No abstract available.

7.

Incidence of Hypersensitivity Reactions During Hemodialysis.

Esteras R, Martín-Navarro J, Ledesma G, Fernández-Prado R, Carreño G, Cintra M, Cidraque I, Sanz I, Tarragón B, Alexandru S, Milla M, Astudillo E, Sánchez E, Mas S, Tejeiro RD, Ortiz A, Sánchez R, González-Parra E.

Kidney Blood Press Res. 2018;43(5):1472-1478. doi: 10.1159/000493662. Epub 2018 Sep 20.

8.

Hydrolysis of Extracellular Pyrophosphate increases in post-hemodialysis plasma.

Azpiazu D, González-Parra E, Egido J, Villa-Bellosta R.

Sci Rep. 2018 Jul 23;8(1):11089. doi: 10.1038/s41598-018-29432-4.

9.

Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.

Castillo-Rodriguez E, Fernandez-Prado R, Esteras R, Perez-Gomez MV, Gracia-Iguacel C, Fernandez-Fernandez B, Kanbay M, Tejedor A, Lazaro A, Ruiz-Ortega M, Gonzalez-Parra E, Sanz AB, Ortiz A, Sanchez-Niño MD.

Toxins (Basel). 2018 Jul 19;10(7). pii: E300. doi: 10.3390/toxins10070300. Review.

10.

Influence of dialysis membrane composition on plasma bisphenol A levels during online hemodiafiltration.

Mas S, Bosch-Panadero E, Abaigar P, Camarero V, Mahillo I, Civantos E, Sanchez-Ospina D, Ruiz-Priego A, Egido J, Ortiz A, González-Parra E.

PLoS One. 2018 Mar 12;13(3):e0193288. doi: 10.1371/journal.pone.0193288. eCollection 2018.

11.

Bisphenol A is an exogenous toxin that promotes mitochondrial injury and death in tubular cells.

Bosch-Panadero E, Mas S, Civantos E, Abaigar P, Camarero V, Ruiz-Priego A, Ortiz A, Egido J, González-Parra E.

Environ Toxicol. 2018 Mar;33(3):325-332. doi: 10.1002/tox.22519. Epub 2017 Dec 7.

PMID:
29214717
12.

Role of pyrophosphate in vascular calcification in chronic kidney disease.

Azpiazu D, Gonzalo S, González-Parra E, Egido J, Villa-Bellosta R.

Nefrologia. 2018 May - Jun;38(3):250-257. doi: 10.1016/j.nefro.2017.07.005. Epub 2017 Nov 11. Review. English, Spanish.

13.

Impact of post-dialysis calcium level on ex vivo rat aortic wall calcification.

Azpiazu D, González-Parra E, Ortiz A, Egido J, Villa-Bellosta R.

PLoS One. 2017 Aug 23;12(8):e0183730. doi: 10.1371/journal.pone.0183730. eCollection 2017.

14.

Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.

Fernandez-Prado R, Esteras R, Perez-Gomez MV, Gracia-Iguacel C, Gonzalez-Parra E, Sanz AB, Ortiz A, Sanchez-Niño MD.

Nutrients. 2017 May 12;9(5). pii: E489. doi: 10.3390/nu9050489. Review.

15.

Atrasentan for the treatment of diabetic nephropathy.

Egido J, Rojas-Rivera J, Mas S, Ruiz-Ortega M, Sanz AB, Gonzalez Parra E, Gomez-Guerrero C.

Expert Opin Investig Drugs. 2017 Jun;26(6):741-750. doi: 10.1080/13543784.2017.1325872. Review.

PMID:
28468519
16.

Correction: Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.

Liappas G, González-Mateo G, Aguirre AR, Abensur H, Albar-Vizcaino P, Parra EG, Sandoval P, Ramírez LG, Del Peso G, Acedo JM, Bajo MA, Selgas R, Sánchez Tomero JA, López-Cabrera M, Aguilera A.

Oncotarget. 2017 Apr 4;8(14):24045. doi: 10.18632/oncotarget.16782. No abstract available.

17.

Differences between 2nd and 3rd generation seric parathormone determination methods on mortality in haemodialysis patients.

Rodríguez-Osorio L, de la Piedra C, Rubert M, Martín-Fernández M, González Casaus ML, Gracia-Iguacel C, Egido J, Villa-Bellosta R, González Parra E.

Nefrologia. 2017 Jul - Aug;37(4):389-396. doi: 10.1016/j.nefro.2016.11.021. Epub 2017 Apr 14. English, Spanish.

18.

The importance of bisphenol A, an uraemic toxin from exogenous sources, in haemodialysis patients.

Mas S, Egido J, González-Parra E; en representación del Grupo de Análisis del Papel del Bisfenol A en el Paciente en Hemodiálisis.

Nefrologia. 2017 May - Jun;37(3):229-234. doi: 10.1016/j.nefro.2017.01.011. Epub 2017 Apr 6. English, Spanish. No abstract available.

19.

Eculizumab in secondary atypical haemolytic uraemic syndrome.

Cavero T, Rabasco C, López A, Román E, Ávila A, Sevillano Á, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, García A, Mendizabal S, Gavela E, Macía M, Quintana LF, María Romera A, Borrego J, Arjona E, Espinosa M, Portolés J, Gracia-Iguacel C, González-Parra E, Aljama P, Morales E, Cao M, Rodríguez de Córdoba S, Praga M.

Nephrol Dial Transplant. 2017 Mar 1;32(3):466-474. doi: 10.1093/ndt/gfw453.

20.

A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients.

Villa-Bellosta R, Rodriguez-Osorio L, Mas S, Abadi Y, Rubert M, de la Piedra C, Gracia-Iguacel C, Mahillo I, Ortiz A, Egido J, González-Parra E.

PLoS One. 2017 Mar 24;12(3):e0173831. doi: 10.1371/journal.pone.0173831. eCollection 2017.

Supplemental Content

Loading ...
Support Center